Key result
Non-obese NAFLD linked to ~6.5-fold greater odds of an E/A ratio < 1 vs controls.
Why the study?
Little is known about the effect of non-obese NAFLD on cardiac function, specifically left ventricular diastolic dysfunction.
Is non-obese NAFLD associated with left ventricular diastolic dysfunction in non-obese adults?
Cross-Sectional (n=316)
No
Is non-obese NAFLD associated with left ventricular diastolic dysfunction in non-obese adults?
Odds Ratio: 6.562 (95% CI 2.014–21.373)
Absolute Event Rate: 83.3% vs 68.9%
p-value: p=0.002
Non-obese NAFLD is associated with a decreased E/A ratio, suggesting early signs of left ventricular diastolic impairment, though overall rates of diagnosed diastolic dysfunction were similar to controls.
Non-obese NAFLD links to subclinical diastolic changes on echo; hypothesis-generating and requires prospective studies before clinical adoption.
Background and aims Non-alcoholic fatty liver disease (NAFLD) is associated with a greater risk of developing cardiovascular disease and have adverse impacts on the cardiac structure and function. Little is known about the effect of non-obese NAFLD upon cardiac function. We aimed to compare the echocardiographic parameters of left ventricle (LV) between non-obese NAFLD group and control group, and explore the correlation of non-obese NAFLD with LV diastolic dysfunction. Methods and results In this cross-sectional study, 316 non-obese inpatients were enrolled, including 72 participants with NAFLD (non-obese NAFLD group) and 244 participants without NAFLD (control group). LV structural and functional indices of two groups were comparatively analyzed. LV diastolic disfunction was diagnosed and graded using the ratio of the peak velocity of the early filling (E) wave to the atrial contraction (A) wave and E value. Compared with control group, the non-obese NAFLD group had the lower E/A〔(0.80 ± 0.22) vs (0.88 ± 0.35), t = 2.528, p = 0.012〕and the smaller LV end-diastolic diameter〔(4.51 ± 0.42)cm vs (4.64 ± 0.43)cm, t = 2.182, p = 0.030〕. And the non-obese NAFLD group had a higher prevalence of E/A < 1 than control group (83.3% vs 68.9%, X 2 = 5.802, p = 0.016) while two groups had similar proportions of LV diastolic dysfunction (58.3% vs 53.7%, X 2 = 0.484, p = 0.487). Multivariate logistic regression analysis showed that non-obese NAFLD was associated with an increase in E/A < 1 (OR = 6.562, 95%CI 2.014, 21.373, p = 0.002). Conclusions Non-obese NAFLD was associated with decrease of E/A, while more research will be necessary to evaluate risk of non-obese NAFLD for LV diastolic dysfunction in future.
No takes yet. Share an insight, caveat, or question.
Cong et al. (2023) conducted a cross-sectional in Non-alcoholic fatty liver disease (NAFLD) (n=316). Non-obese NAFLD vs. Non-obese without NAFLD was evaluated on E/A < 1 (decreased ratio of peak velocity of early filling to atrial contraction) (OR 6.562, 95% CI 2.014-21.373, p=0.002). Non-obese NAFLD was independently associated with a significantly increased risk of having an E/A ratio < 1 (OR 6.562) compared to non-obese controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: